Skip to main content

Month: August 2025

Genco Shipping & Trading Limited Announces Q2 2025 Financial Results

Declares Dividend of $0.15 per share for Q2 2025Represents Genco’s 24th Consecutive Quarterly Dividend Announces Acquisition of High-Specification Capesize Vessel NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today reported its financial results for the three months and six months ended June 30, 2025. Second Quarter 2025 and Year-to-Date HighlightsDividendDeclared a $0.15 per share dividend for Q2 2025 24th consecutive quarterly dividendCumulative dividends of $6.915 per share or approximately 41% of our current share price1Q2 2025 dividend is payable on or about August 25, 2025 to all shareholders of record as of August 18, 2025GrowthAgreed...

Continue reading

NL REPORTS SECOND QUARTER 2025 RESULTS

Dallas, Texas, Aug. 06, 2025 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported net income attributable to NL stockholders of $.3 million, or $.01 per share, in the second quarter of 2025 compared to $7.9 million, or $.16 per share, in the second quarter of 2024. NL’s results include an unrealized loss of $.1 million in the second quarter of 2025 related to the change in value of marketable equity securities compared to an unrealized gain of $.8 million in the second quarter of 2024. For the first six months of 2025, NL reported net income attributable to NL stockholders of $1.0 million, or $.02 per share, compared to $14.7 million, or $.30 per share for the first six months of 2024. NL results include an unrealized loss of $8.6 million in the first six months of 2025 related to the change in value of marketable equity...

Continue reading

PhenixFIN Corporation Announces Fiscal Third Quarter 2025 Financial Results

NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) — PhenixFIN Corporation (NASDAQ: PFX, PFXNZ) (the “Company”), a publicly traded business development company, today announced its financial results for the fiscal third quarter for its year ending September 30, 2025. Highlights:Third quarter total investment income of $6.2 million; net investment income of $1.2 million Net asset value (NAV) of $157 million, or $78.20 per share as of June 30, 2025 On April 17, 2025, amended the credit facility to $100mm with a $50mm accordion, reduction in pricing to SOFR+2.50% and extended maturity to April 17, 2030 Weighted average yield was 12.66% on debt and other income producing investments“We continue to see solid performance from the portfolio despite a more volatile macro environment.” commented David Lorber, Chief Executive Officer, “We had...

Continue reading

APA Corporation Announces Second-Quarter 2025 Financial and Operational Results

HOUSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today announced second-quarter 2025 results. Results can be found on the company’s website by visiting www.apacorp.com or investor.apacorp.com. APA will host a conference call on Aug. 7 at 10 a.m. Central time via the webcast link available on the company website to discuss the results. Following the conference call, a replay will be available for one year on the “Investors” page of the company’s website. About APA APA Corporation owns consolidated subsidiaries that explore for and produce oil and natural gas in the United States, Egypt and the United Kingdom and that explore for oil and natural gas offshore Suriname and elsewhere. APA posts announcements, operational updates, investor information and press releases on its website, www.apacorp.com.Contacts     Investor: (281)...

Continue reading

Occidental Announces Second Quarter 2025 Results

HOUSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) today announced its second quarter 2025 financial results. The earnings release and accompanying financial schedules can be accessed via the Investor Relations section of the company’s website, oxy.com. The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call to discuss the results on Thursday, August 7, 2025, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10200631/ff63fe0694. A recording of the webcast will be posted on the Investor Relations section of the company’s...

Continue reading

Anaptys Announces Second Quarter 2025 Financial Results and Provides Business Update

Announces positive data for rosnilimab, a pathogenic T cell depleter, through Week 38 from Phase 2b rheumatoid arthritis trial Enrollment completed for rosnilimab Phase 2 ulcerative colitis trial; Top-line data through Week 12 on track for Q4 2025 Ongoing Phase 1 trials in healthy volunteers for ANB033, a CD122 antagonist, and ANB101, a BDCA2 modulator Plan to initiate Phase 1b cohort for ANB033 in initial indication, celiac disease, by Q4 2025; additional information to be disclosed at ANB033-focused R&D event in Q4 2025 Anticipate triggering a $75 million commercial sales milestone from GSK in 2025 once Jemperli achieves $1 billion in worldwide net sales in a calendar yearSAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative...

Continue reading

Leslie’s, Inc. Announces Third Quarter Fiscal 2025 Financial Results

PHOENIX, Aug. 06, 2025 (GLOBE NEWSWIRE) — Leslie’s, Inc. (NASDAQ: LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced its financial results for the third quarter of fiscal 2025.     “As we announced last month in our preliminary financial results, our results were below expectations in the fiscal third quarter. Against a challenging backdrop in what is normally our peak selling season of the year, we faced significant headwinds from weather in addition to competitive pricing dynamics that were magnified in a compressed demand period,” said Jason McDonell, Leslie’s chief executive officer. “Our team worked diligently to mitigate costs amongst the challenging sales backdrop in the quarter, including reducing...

Continue reading

CoreCivic Reports Second Quarter 2025 Financial Results

Raises 2025 Full Year Guidance Increasing Demand Drives Strong Financial Performance BRENTWOOD, Tenn., Aug. 06, 2025 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (CoreCivic or the Company) announced today its second quarter 2025 financial results.   Financial Highlights – Second Quarter 2025Total revenue of $538.2 million, up 9.8% from the prior year quarter Net income of $38.5 million, up 103.4% from the prior year quarter Diluted earnings per share of $0.35, up 105.9% from the prior year quarter Adjusted diluted earnings per share of $0.36, up 80.0% from the prior year quarter Normalized FFO per diluted share of $0.59, up 40.5% from the prior year quarter Adjusted EBITDA of $103.3 million, up 23.2% from the prior year quarter Repurchased 2.0 million shares of our common stock at an aggregate cost of $43.2 millionDamon...

Continue reading

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

Second Quarter 2025 Total Revenues of $140.9 million, above Q2 guidance by $21 million Second Quarter 2025 Net Loss of $12.0 million and Net Loss Margin of (9)%, an improvement of 96% and 10,200 bps, respectively, versus prior year Second Quarter 2025 Gross Margin % of 36% and Adjusted Gross Margin % of 49%, an expansion of 6,200 bps and 2,300 bps, respectively, versus prior year Second Quarter 2025 Adjusted EBITDA of $28.5 million, an increase of 382% versus prior year Second Quarter 2025 Adjusted EBITDA Margin of 20% of Total Revenues, an improvement of 2,400 bps versus prior year Raising the low end/midpoint of Full Year 2025 Profitability GuidanceGAITHERSBURG, Md., Aug. 06, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2025. “Our second...

Continue reading

Montauk Renewables Announces Second Quarter 2025 Results

PITTSBURGH, Aug. 06, 2025 (GLOBE NEWSWIRE) — Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery, and conversion of biogas into renewable natural gas (“RNG”), today announced financial results for the second quarter ended June 30, 2025. Second Quarter Highlights:Revenues of $45.1. million, increased 4.1% compared to the second quarter of 20243.0 million RINs generated and unseparated as of June 30, 2025 Non-GAAP Adjusted EBITDA of $5.0 million, decreased 27.7% year-over-yearRNG production of 1.4 million MMBtu, flat compared to second quarter of 2024RINs sold of 11.1 million, increased 1.1 million or 10.5% year-over-yearIn the second quarter of 2025, we successfully completed the construction and commissioning of the second RNG processing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.